23 September 2009

Teva and Lundbeck announce New England Journal of Medicine publication of landmark ADAGIO study with Azilect® in Parkinson’s disease

23 September 2009

Teva and Lundbeck announce New England Journal of Medicine publication of landmark ADAGIO study with Azilect® in Parkinson’s disease

Results of early treatment with AZILECT® 1 mg/day tablets consistent with disease-modifying effect 24th September 2009. Teva and Lundbeck announce that the results of the ADAGIO trial were published online today by the New England Journal of Medicine. Patients who received Azilect® (rasagiline) 1mg/day at the start of the study (early-start group) experienced significantly superior [...]